ADJUVANCY AND REACTOGENICITY OF N-ACETYLGLUCOSAMINYL N-ACETYLMURAMYL DIPEPTIDE (GMDP) ORALLY-ADMINISTERED JUST PRIOR TO TRIVALENT INFLUENZASUBUNIT VACCINE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN NURSING-HOME RESIDENTS
Am. Palache et al., ADJUVANCY AND REACTOGENICITY OF N-ACETYLGLUCOSAMINYL N-ACETYLMURAMYL DIPEPTIDE (GMDP) ORALLY-ADMINISTERED JUST PRIOR TO TRIVALENT INFLUENZASUBUNIT VACCINE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN NURSING-HOME RESIDENTS, Vaccine, 14(14), 1996, pp. 1327-1330
One hundred and fifty-three nursing home residents received 0, 5, 25 o
r 50 mg N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally,
and trivalent influenza subunit vaccine intramuscularly, One day after
intervention, there was a strong increase of total leucocytes, monocy
tes and neutrophils in the groups receiving 25 or 50 mg GMDP. A GMDP d
ose dependent increase in systemic, but not in local, vaccine side-eff
ects was observed. No significant differences in post-vaccination haem
agglutination inhibiting serum antibody titres were observed between t
he four groups, indicating that oral administration of GMDP together w
ith influenza vaccination, does not lead to a higher vaccine efficacy.
Copyright (C) 1996 Elsevier Science Ltd.